Clinical outcomes in chronic intervillositis of unknown etiology.


Journal

Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349

Informations de publication

Date de publication:
02 2020
Historique:
received: 27 09 2019
revised: 29 12 2019
accepted: 03 01 2020
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 9 2 2021
Statut: ppublish

Résumé

Chronic intervillositis of unknown etiology (CIUE) is a histopathological lesion of the placenta that is frequently accompanied by unfavourable pregnancy outcomes, e.g. miscarriage, fetal growth restriction (FGR) and intrauterine fetal death. Earlier described case series and cohorts have been based on diverse diagnostic criteria of CIUE. To improve our understanding of clinical outcomes associated with CIUE, we report the obstetric and perinatal outcomes in a cohort based on the recently described diagnostic criteria. CIUE is defined as an infiltrate occupying 5% or more of the intervillous space with approximately 80% of mononuclear cells positive for CD68 in the absence of an infection. Thirty-eight cases were included. Also previous and subsequent pregnancies were described. Pregnancies accompanied by CIUE frequently resulted in FGR (51.6%) and pre-term birth (55.3%). Twenty-nine out of 38 pregnancies (76.3%) with CIUE resulted in a living baby. Women with CIUE frequently have had a miscarriage (16/38; 42%). Four-teen subsequent pregnancies in 8 women resulted in 2 miscarriages, 2 terminations of pregnancy for FGR, 1 early neonatal death and 9 living babies (9/14; 64.3%). Histopathologically confirmed CIUE recurred in 5 out of 10 subsequent pregnancies. Two pregnancies with recurrent CIUE were terminated, one pregnancy ended in a late miscarriage and another resulted in term birth complicated by FGR. Recurrent CIUE can also be accompanied by an uncomplicated pregnancy (1/5; 20%). This study provides additional insight into the clinical phenotype of CIUE and emphasises the need for further research to understand the pathophysiology behind different pregnancy outcomes in CIUE.

Identifiants

pubmed: 32174302
pii: S0143-4004(20)30001-1
doi: 10.1016/j.placenta.2020.01.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-23

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

M Bos (M)

Department of Pathology, Leiden University Medical Center, the Netherlands; Department of Obstetrics and Gynaecology, Leiden University Medical Center, the Netherlands. Electronic address: m.bos@lumc.nl.

E T M S Harris-Mostert (ETMS)

Department of Pathology, Leiden University Medical Center, the Netherlands.

L E van der Meeren (LE)

Department of Pathology, University Medical Center Utrecht, the Netherlands.

J J Baelde (JJ)

Department of Pathology, Leiden University Medical Center, the Netherlands.

D J Williams (DJ)

Institute for Women's Health, University College London Hospitals, United Kingdom.

P G J Nikkels (PGJ)

Department of Pathology, University Medical Center Utrecht, the Netherlands.

K W M Bloemenkamp (KWM)

Department of Obstetrics, Birth Center Wilhelmina's Children Hospital, Division Woman and Baby, University Medical Center Utrecht, the Netherlands.

M L P van der Hoorn (MLP)

Department of Obstetrics and Gynaecology, Leiden University Medical Center, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH